> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# KV Pharma’s Micro-K LS Not Withdrawn Over Safety/Efficacy
- URL: https://www.fdaweb.com/kv-pharmas-micro-k-ls-not-withdrawn-over-safety-efficacy/
- Published: 2020-09-02T12:00:00.000Z
- Updated: 2026-09-14T16:27:27.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5147566

*Federal Register* notice: FDA has determined that KV Pharmaceuticalֺ’s Micro-K LS (potassium chloride) extended-release liquid suspension, 20 milliequivalents/packet, was not withdrawn for safety or effectiveness reasons. The determination will allow FDA to approve ANDAs that reference the product if all other legal and regulatory requirements are met. Micro-K LS is indicated for treating patients with hypokalemia, with or without metabolic alkalosis; in digitalis intoxication; and in patients with hypokalemic familial periodic paralysis. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2020-09-02/pdf/2020-19369.pdf?ref=fdaweb.com).